A senator is calling for an independent inquiry into sodium valproate (Epilim) – an epilepsy drug linked to birth defects. Rose Conway-Walsh, (Sinn Fein), told The Times Ireland Edition that a "do-nothing" approach was not acceptable.
Last June, an Oireachtas report backed an independent inquiry into the controversy. The Committee, chaired by Dr Michael Harty TD, emphasised their support for those affected and made a number of recommendations which included "the establishment of an independent investigation to examine the historical use of valproate in Ireland and into its ongoing effects."
The Department of Health have committed to several requests, including visual warnings on the drug's packaging. While expressing support for the Oireachtas report, the Government has not committed to compensation or an independent review for those affected by the drug.
Ms Conway-Walsh said that the state must establish a redress scheme to meet "the lifelong care needs of children and the impact of diagnosis on families."
"I know families who desperately need therapies and treatment but they cannot afford them. They sit and watch while their children regress. This is an intolerable situation and must stop."
Last month, The Minister for Disabilities Finian McGrath told the Seanad in relation to compensation: "This issue is particularly complex given the number of different parties involved to one degree or other, where a woman is prescribed and dispensed sodium valproate."